BD Announces Results For 2018 Third Fiscal Quarter; Raises Fiscal 2018 Revenue Guidance
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: PR Newswire
FRANKLIN LAKES, N.J., Aug. 2, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.278 billion for the third fiscal quarter ended June 30, 2018. This represents an increase of 41.0 percent from the prior-year period, which is primarily due to the acquisition of C. R. Bard. On a comparable, currency-neutral basis that includes the revenues of C.R. Bard in the current and prior year, revenues increased 5.5 percent over the prior-year period."Our strong revenue growth and operating performance this quarter demonstrate that we are delivering on our strategy," said Vincent A. Forlenza, Chairman and CEO. "We are on track with the integration of C. R. Bard and continue to deliver on our financial commitments while providing innovative solutions for our customers and their patients worldwide."Third Quarter and Nine-Month Fiscal 2018 Operating Results As reported, diluted earnings per share
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- 2024 Report | European Biopsy Devices Market to Reach US$ 1,074.0 Million by 2032: Enhanced Focus on Early Disease Detection Fuels Growth [Yahoo! Finance]Yahoo! Finance
- Sepsis Diagnostics Market is Expected to Reach $890 million | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- AvaSure Appoints Technology Veteran Paula Cobb as Vice President of Marketing [Yahoo! Finance]Yahoo! Finance
- Injectable Drug Delivery Market To Reach USD 1,714.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- BDX or MMSI: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 2/1/24 - Beat
BDX
Sec Filings
- 4/5/24 - Form 4
- 3/15/24 - Form 4
- 3/14/24 - Form 144
- BDX's page on the SEC website